Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a longevity-focused regenerative and cellular medicine company, today announced that it has filed its Annual Report on Form 10-K for the ...
Celularity Inc., a Florham Park-based biotech company, appointed Dr. Adrian Kilcoyne as executive vice president, chief medical officer and head of global medical affairs, patient safety and patient ...
Florham Park-based Celularity Inc. said Sept. 15 that it hired Andrew Pecora as its president, effective immediately. Pecora, who previously founded Cota Inc., a data and analytics company that works ...
Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative and cellular medicine company, today announced the closing of its previously announced transaction with NexGel, Inc.
BUCKSCO.Today on MSN
Langhorne’s Nexgel transforms near disaster into ‘three-team trade’ acquisition
Despite the withdrawal of an investor, Langhorne-based Nexgel successfully finalized its acquisition of Celularity’s ...
FLORHAM PARK, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company addressing age-related and degenerative diseases, ...
FLORHAM PARK, N.J., June 02, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, today announced its research published in ...
Data published online in the journal Cytotherapy demonstrate that CRISPR-mediated tissue factor gene knockout (TFKO) in allogeneic stromal cells (ASCs) leads to significantly lower tissue factor (TF) ...
FLORHAM PARK, N.J., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company focused on addressing age-related and ...
FLORHAM PARK, N.J.--(BUSINESS WIRE)--Celularity, Inc. (Nasdaq: CELU) (“Celularity” or “the Company”), a clinical-stage biotechnology company developing placental-derived allogenic cell therapies and ...
FLORHAM PARK, N.J., April 17, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”), a longevity-focused regenerative and cellular medicine company, today announced that on April 16, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results